000 01692 a2200517 4500
005 20250513052006.0
264 0 _c19941028
008 199410s 0 0 eng d
022 _a0171-5216
024 7 _a10.1007/BF01212812
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPerego, P
245 0 0 _aCharacterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs.
_h[electronic resource]
260 _bJournal of cancer research and clinical oncology
_c1994
300 _a585-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aBiopsy
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aChromosome Banding
650 0 4 _aCulture Techniques
_xmethods
650 0 4 _aGlioblastoma
_xgenetics
650 0 4 _aGlutathione
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKaryotyping
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMiddle Aged
650 0 4 _aTransplantation, Heterologous
650 0 4 _aTumor Cells, Cultured
650 0 4 _agamma-Glutamyltransferase
_xmetabolism
700 1 _aBoiardi, A
700 1 _aCarenini, N
700 1 _aDe Cesare, M
700 1 _aDolfini, E
700 1 _aMagnani, I
700 1 _aMartignone, S
700 1 _aSilvani, A
700 1 _aSoranzo, C
773 0 _tJournal of cancer research and clinical oncology
_gvol. 120
_gno. 10
_gp. 585-92
856 4 0 _uhttps://doi.org/10.1007/BF01212812
_zAvailable from publisher's website
999 _c7928858
_d7928858